314 related articles for article (PubMed ID: 11889080)
21. The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest.
Fujii D; Yoshida K; Tanabe K; Hihara J; Toge T
Anticancer Res; 2004; 24(3a):1409-16. PubMed ID: 15274302
[TBL] [Abstract][Full Text] [Related]
22. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer.
Mueller E; Smith M; Sarraf P; Kroll T; Aiyer A; Kaufman DS; Oh W; Demetri G; Figg WD; Zhou XP; Eng C; Spiegelman BM; Kantoff PW
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10990-5. PubMed ID: 10984506
[TBL] [Abstract][Full Text] [Related]
23. Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice.
Elstner E; Müller C; Koshizuka K; Williamson EA; Park D; Asou H; Shintaku P; Said JW; Heber D; Koeffler HP
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8806-11. PubMed ID: 9671760
[TBL] [Abstract][Full Text] [Related]
24. Troglitazone suppresses cell growth of KU812 cells independently of PPARgamma.
Abe A; Kiriyama Y; Hirano M; Miura T; Kamiya H; Harashima H; Tokumitsu Y
Eur J Pharmacol; 2002 Feb; 436(1-2):7-13. PubMed ID: 11834241
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptor gamma reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1.
Toyota M; Miyazaki Y; Kitamura S; Nagasawa Y; Kiyohara T; Shinomura Y; Matsuzawa Y
Life Sci; 2002 Feb; 70(13):1565-75. PubMed ID: 11895107
[TBL] [Abstract][Full Text] [Related]
26. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
27. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity.
Baek SJ; Wilson LC; Hsi LC; Eling TE
J Biol Chem; 2003 Feb; 278(8):5845-53. PubMed ID: 12475986
[TBL] [Abstract][Full Text] [Related]
28. Critical role of c-Jun N-terminal protein kinase activation in troglitazone-induced apoptosis of human HepG2 hepatoma cells.
Bae MA; Song BJ
Mol Pharmacol; 2003 Feb; 63(2):401-8. PubMed ID: 12527812
[TBL] [Abstract][Full Text] [Related]
29. Troglitazone inhibits growth of MCF-7 breast carcinoma cells by targeting G1 cell cycle regulators.
Yin F; Wakino S; Liu Z; Kim S; Hsueh WA; Collins AR; Van Herle AJ; Law RE
Biochem Biophys Res Commun; 2001 Sep; 286(5):916-22. PubMed ID: 11527386
[TBL] [Abstract][Full Text] [Related]
30. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma.
Mössner R; Schulz U; Krüger U; Middel P; Schinner S; Füzesi L; Neumann C; Reich K
J Invest Dermatol; 2002 Sep; 119(3):576-82. PubMed ID: 12230498
[TBL] [Abstract][Full Text] [Related]
31. Activation of peroxisome proliferator-activated receptor-gamma inhibits apoptosis induced by serum deprivation in LLC-PK1 cells.
Haraguchi K; Shimura H; Onaya T
Exp Nephrol; 2002; 10(5-6):393-401. PubMed ID: 12381924
[TBL] [Abstract][Full Text] [Related]
32. Growth inhibition and differentiation of pancreatic cancer cell lines by PPAR gamma ligand troglitazone.
Kawa S; Nikaido T; Unno H; Usuda N; Nakayama K; Kiyosawa K
Pancreas; 2002 Jan; 24(1):1-7. PubMed ID: 11741176
[TBL] [Abstract][Full Text] [Related]
33. Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells.
Nakashiro KI; Hayashi Y; Kita A; Tamatani T; Chlenski A; Usuda N; Hattori K; Reddy JK; Oyasu R
Am J Pathol; 2001 Aug; 159(2):591-7. PubMed ID: 11485917
[TBL] [Abstract][Full Text] [Related]
34. Activation of peroxisome proliferator-activated receptor gamma inhibits the growth of human pancreatic cancer.
Sasaki T; Fujimoto Y; Tsuchida A; Kawasaki Y; Kuwada Y; Chayama K
Pathobiology; 2001; 69(5):258-65. PubMed ID: 12107343
[TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Hashimoto K; Ethridge RT; Evers BM
Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
[TBL] [Abstract][Full Text] [Related]
36. A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells.
Akasaki Y; Liu G; Matundan HH; Ng H; Yuan X; Zeng Z; Black KL; Yu JS
J Biol Chem; 2006 Mar; 281(10):6165-74. PubMed ID: 16319070
[TBL] [Abstract][Full Text] [Related]
37. Troglitazone, a ligand for peroxisome proliferator-activated receptor gamma, inhibits chemically-induced aberrant crypt foci in rats.
Kohno H; Yoshitani S; Takashima S; Okumura A; Hosokawa M; Yamaguchi N; Tanaka T
Jpn J Cancer Res; 2001 Apr; 92(4):396-403. PubMed ID: 11346461
[TBL] [Abstract][Full Text] [Related]
38. Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells.
Satoh T; Toyoda M; Hoshino H; Monden T; Yamada M; Shimizu H; Miyamoto K; Mori M
Oncogene; 2002 Mar; 21(14):2171-80. PubMed ID: 11948400
[TBL] [Abstract][Full Text] [Related]
39. Growth inhibition of pancreatic cancer cells through activation of peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Tsujie M; Nakamori S; Okami J; Takahashi Y; Hayashi N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Int J Oncol; 2003 Aug; 23(2):325-31. PubMed ID: 12851681
[TBL] [Abstract][Full Text] [Related]
40. Troglitazone, a peroxisome proliferator-activated receptor gamma ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells.
Zhou YM; Wen YH; Kang XY; Qian HH; Yang JM; Yin ZF
World J Gastroenterol; 2008 Apr; 14(14):2168-73. PubMed ID: 18407589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
